Benefits persist in T cell therapy for children with relapsed leukemia
- OPACC
- Dec 8, 2014
- 1 min read
An innovative cell therapy against a highly aggressive form of acute lymphoblastic leukemia (ALL) continues to show highly promising results in children treated in a pilot study.
Comments